People Suffering with Alzheimer’s May Benefit from Early Treatment with Solanezumab
Scientists have identified that people with mild Alzheimer’s condition obtaining early treatment with the new medicine solanezumab benefited more than
Read moreeli lilly
Federal Appeals Court Supports Eli Lilly’s Strattera Patent
Earlier on Friday, Eli Lilly announced that a federal appeals court upturned a decision that would permit generic sales of
Read more